Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10
Published March 26, 2014 · Recall initiated: March 3, 2014
Summary
FDA records drug Class III recall D-1167-2014, published March 26, 2014 and initiated March 3, 2014. Recalling firm: McKesson Packaging Services; Status: Terminated; Reported quantity: 1,557 Boxes; Lot: Lot #: 91357. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- McKesson Packaging Services
- Distributor
- Nationwide
- Lot
- Lot #: 91357
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAdvil PM Caplets, (Ibuprofen, 200 mg /Diphenhydramine citrate, 38 mg) 120 count bottle, OTC, Pfizer, Madison,March 26, 2014
- FDAPerrigo, Clindamycin Palmitate Hydrochloride for Oral Solution, USP, 75mg/5mL, 100 ml, NDC 0574-0129-01March 26, 2014
- FDAGuaifenesin USP, 50 Kg Drums, CAS No. 93-14-1, Reg. No. 05436, Caution: For Manufacturing, Processing, orMarch 26, 2014
- FDAClalis capsules, 50 mg, 6 -count bottle ( labeling is in foreign language)March 26, 2014
- FDAbuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, UD 100 Tablets (10 x 10) per carton, Rx only,October 10, 2012
- FDAbuPROPion Hydrochloride Extended-Release Tablets (XL), 150 mg, UD 100 Tablets (10 x 10) per carton, Rx only,October 10, 2012
Questions about this recall
Was Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10 recalled?
Yes. FDA published recall D-1167-2014 on March 26, 2014. Reported hazard: Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.
What should I do if I have this product?
Voluntary: Firm initiated · Letter